The oral microbiota is modified by systemic diseases.
Open accessAbstract
Periodontal diseases are initiated by bacteria that accumulate in a biofilm on the tooth surface and affect the adjacent periodontal tissue. Systemic diseases such as diabetes, rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) increase susceptibility to destructive periodontal diseases. In human studies and in animal models, these diseases have been shown to enhance inflammation in the periodontium and increase the risk or severity of periodontitis. All 3 systemic diseases are linked to a decrease in bacterial taxa associated with health and an increase in taxa associated with disease. Although there is controversy regarding the specific oral bacterial changes associated with each disease, it has been reported that diabetes increases the levels of Capnocytophaga, Porphyromonas, and Pseudomonas, while Prevotella and Selenomonas are increased in RA and Selenomonas, Leptotrichia, and Prevotella in SLE. In an animal model, diabetes increased the pathogenicity of the oral microbiome, as shown by increased inflammation, osteoclastogenesis, and periodontal bone loss when transferred to normal germ-free hosts. Moreover, in diabetic animals, the increased pathogenicity could be substantially reversed by inhibition of IL-17, indicating that host inflammation altered the microbial pathogenicity. Increased IL-17 has also been shown in SLE, RA, and leukocyte adhesion deficiency and may contribute to oral microbial changes in these diseases. Successful RA treatment with anti-inflammatory drugs partially reverses the oral microbial dysbiosis. Together, these data demonstrate that systemic diseases characterized by enhanced inflammation disturb the oral microbiota and point to IL-17 as key mediator in this process.
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that systemic inflammatory diseases—diabetes, rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE)—modify the oral microbiota by reducing health-associated taxa and increasing disease-associated taxa, with IL-17 proposed as a key mediator. In animal models, diabetic oral microbiota transfer increased inflammation and periodontal bone loss, and IL-17 inhibition substantially reversed this increased pathogenicity.
Key findings
- Diabetes, RA, and SLE are linked to decreased bacterial taxa associated with health and increased taxa associated with disease; reported increases include *Capnocytophaga*, *Porphyromonas*, and *Pseudomonas* in diabetes, *Prevotella* and *Selenomonas* in RA, and *Selenomonas*, *Leptotrichia*, and *Prevotella* in SLE.
- In diabetic mice, transfer of oral microbiota to normal germ-free hosts increased neutrophil infiltration, IL-6 and RANKL expression, osteoclast numbers, and periodontal bone loss compared with transfer from normoglycemic donors; inhibition of IL-17 shifted the microbiota toward a normoglycemic profile and reduced its capacity to stimulate inflammation and alveolar bone loss.
- Human periodontitis data cited include 47% of US adults with evidence of periodontitis and 10% to 15% with advanced periodontitis; periodontitis subjects can show up to a 3-log increase in subgingival bacterial load. RA increased microbial biomass approximately 1-log, and a meta-analysis reported a 1.76-fold increased risk of periodontal disease in SLE subjects.
- Successful RA treatment with anti-inflammatory drugs partially reverses oral microbial dysbiosis, and periodontal treatment improves response to conventional therapy in SLE patients with reduced disease activity.
Methods
- Narrative review synthesizing human studies and animal models on oral microbiota changes associated with diabetes, RA, and SLE.
- Includes discussion of a longitudinal mouse model of spontaneous diabetes and germ-free transfer experiments, plus tables summarizing bacterial community changes.
- No new primary data are presented; the paper cites published literature and refers to some unpublished results from the authors.
Limitations
- The paper states that human studies have not revealed consistent diabetes-induced microbial changes, citing potential false positives from large numbers of oral microorganisms, insufficient subject numbers, confounding factors such as degree of hyperglycemia, disease duration and medications, technical limitations, and limited longitudinal studies.
- The paper states that functional studies linking specific microbiota disturbances and inflammatory pathways with periodontal damage in SLE have not been reported as they have for diabetes, and that the IL-17 hypothesis and downstream events need further investigation.
- Evident from the text: as a narrative review, it relies on heterogeneous studies and includes unpublished results, without a described systematic search or quantitative synthesis; the paper also notes that assigning taxa as “good” and “bad” is an oversimplification.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 125 cited sources checked · 0 supported · 0 flagged
- Findingcitation§ Abstract
In diabetic animals, the increased pathogenicity of the oral microbiome could be substantially reversed by inhibition of IL-17.
“Moreover, in diabetic animals, the increased pathogenicity could be substantially reversed by inhibition of IL-17, indicating that host inflammation altered the microbial pathogenicity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xiao et al. 2017
Not checked in the free run.
- Rests on an assumption: Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
- Findingcitation§ Abstract
In an animal model, diabetes increased the pathogenicity of the oral microbiome, as shown by increased inflammation, osteoclastogenesis, and periodontal bone loss when transferred to normal germ-free hosts.
“In an animal model, diabetes increased the pathogenicity of the oral microbiome, as shown by increased inflammation, osteoclastogenesis, and periodontal bone loss when transferred to normal germ-free hosts.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xiao et al. 2017
Not checked in the free run.
- Rests on an assumption: Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
- Findingown data§ Abstract
Diabetes-prone and normoglycemic littermates initially had similar oral microbiomes.
“The diabetes-prone and normoglycemic littermates initially had similar oral microbiomes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xiao et al. 2017
Not checked in the free run.
- Rests on an assumption: Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
- Findingcitation§ Abstract
Diabetes reduced the diversity of oral microbiota.
“Diabetes also reduced the diversity of oral microbiota as reported in other tissues where diabetes reduces bacterial diversity (Ussar et al. 2016).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Xiao et al. 2017
Not checked in the free run.
- cites Ussar et al. 2016
Not checked in the free run.
- Rests on an assumption: Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
- Findingown data§ Abstract
IL-17 inhibition decreased the capacity of bacteria from diabetic animals to stimulate inflammation and alveolar bone loss in normal germ-free recipients.
“IL-17 inhibition decreased the capacity of bacteria from diabetic animals to stimulate inflammation and alveolar bone loss in normal germ-free recipients.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xiao et al. 2017
Not checked in the free run.
- Rests on an assumption: Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
- Findingcitation§ Abstract
Rheumatoid arthritis subjects have a reduction of health-associated species (Streptococcus, Rothia aeria, Kingella oralis, Haemophilus, and Actinomyces).
“In addition, RA subjects have a reduction of health-associated species (Streptococcus, Rothia aeria, Kingella oralis, Haemophilus, and Actinomyces) (Corrêa et al. 2018, unpublished data).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Corrêa et al. 2018, unpublished data
Not checked in the free run.
- Findingcitation§ Abstract
Rheumatoid arthritis patients without periodontitis have an enrichment in periodontitis-associated bacteria, such as Prevotella (e.g., P. melaninogenica, P. denticola, P. histicola, P. nigrescens, P. oulorum, and P. maculosa), and other pathogenic species (S. noxia, S. sputigena, and Anaeroglobus geminatus).
“RA patients without periodontitis have an enrichment in periodontitis-associated bacteria, such as Prevotella (e.g., P. melaninogenica, P. denticola, P. histicola, P. nigrescens, P. oulorum, and P. maculosa), and other pathogenic species (S. noxia, S. sputigena, and Anaeroglobus geminatus) (Corrêa et al. 2018, unpublished data).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Corrêa et al. 2018, unpublished data
Not checked in the free run.
- Premisecitation§ Abstract
Systemic diseases with increased inflammation are frequently linked to increased risk of periodontal disease.
“Systemic diseases with increased inflammation are frequently linked to increased risk of periodontal disease (Jepsen et al. 2018).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Jepsen et al. 2018
Not checked in the free run.
- Interpretationreasoning§ Abstract
Host inflammation altered the microbial pathogenicity.
“indicating that host inflammation altered the microbial pathogenicity”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
Periodontitis is associated with a shift in the bacterial community structure and composition.
“Periodontitis is associated with a shift in the bacterial community structure and composition (Dewhirst 2010; Diaz 2012; Griffen et al. 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Dewhirst 2010
Not checked in the free run.
- cites Diaz 2012
Not checked in the free run.
- cites Griffen et al. 2012
Not checked in the free run.
- Interpretationreasoning§ Abstract
The dynamic balance among various bacterial taxa is likely to be instrumental in determining periodontal disease activity.
“Thus, the dynamic balance among various bacterial taxa is likely to be instrumental in determining periodontal disease activity.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
In periodontitis subjects, there is an increased bacterial biomass with up to a 3-log increase in subgingival bacterial load.
“A noticeable change in this equilibrium is quantitative, with an increased bacterial biomass with up to a 3-log increase in subgingival bacterial load in periodontitis subjects (Diaz 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Diaz 2012
Not checked in the free run.
- Premisecitation§ Abstract
Putative periodontal pathogens are often found at healthy sites with no evidence of periodontal breakdown.
“Putative periodontal pathogens are often found at healthy sites with no evidence of periodontal breakdown (Dewhirst 2010; Diaz 2012; Griffen et al. 2012).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Dewhirst 2010
Not checked in the free run.
- cites Diaz 2012
Not checked in the free run.
- cites Griffen et al. 2012
Not checked in the free run.
- Premisecitation§ Abstract
A combination of Bacteroides forsythus, Porphyromonas gingivalis, and Treponema denticola is highly associated with clinical measures of periodontal disease.
“Socransky and colleagues (1998) identified combinations of Bacteroides forsythus, Porphyromonas gingivalis, and Treponema denticola as being highly associated with clinical measures of periodontal disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Socransky et al. 1998
Not checked in the free run.
- Premisecitation§ Abstract
In gingivitis and periodontitis, there is likely to be an alteration in microbial composition or bacterial pathogenicity, referred to as microbial dysbiosis.
“In gingivitis and periodontitis, there is likely to be an alteration in microbial composition or bacterial pathogenicity which is currently referred to as microbial dysbiosis (Roberts and Darveau 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Roberts and Darveau 2015
Not checked in the free run.
- Premisecitation§ Abstract
A combination of Aggregatibacter actinomycetemcomitans, Streptococcus parasanguinis, and Filifactor alocis is associated with bone loss in localized aggressive periodontitis.
“Fine and coworkers (2013) reported that a combination of Aggregatibacter actinomycetemcomitans, Streptococcus parasanguinis, and Filifactor alocis was associated with bone loss in localized aggressive periodontitis (Fine et al. 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fine et al. 2013
Not checked in the free run.
- Interpretationreasoning§ Abstract
The increased inflammation in diabetes, systemic lupus erythematosus, and rheumatoid arthritis provides a common framework for altering the oral microbiota.
“The increased inflammation in each of these diseases provides a common framework for altering the oral microbiota.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Abstract
Systemic diseases characterized by enhanced inflammation disturb the oral microbiota.
“Together, these data demonstrate that systemic diseases characterized by enhanced inflammation disturb the oral microbiota”
Quote in the paperSubstantial claim - Premisenone given§ Abstract
Periodontitis is initiated by bacteria that are likely already present, rather than by the introduction of an exogenous taxa.
“Unlike many infectious diseases, periodontitis is initiated by bacteria that are likely already present, rather than by the introduction of an exogenous taxa.”
Quote in the paperNot a substantial claim - Interpretationreasoning§ Abstract
IL-17 is a key mediator in the process by which systemic diseases disturb the oral microbiota.
“and point to IL-17 as key mediator in this process”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
Diabetes mellitus has one of the strongest linkages to periodontitis among systemic diseases.
“Systemic diseases have a significant impact on periodontitis, with diabetes mellitus having one of the strongest linkages.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wu et al. 2015
Not checked in the free run.
- Premisecitation§ Abstract
Inoculation of the same bacterial load in the connective tissue of diabetic animals stimulates a greater inflammatory response compared with normoglycemic controls.
“Inoculation of the same bacterial load in the connective tissue of diabetic animals stimulates a greater inflammatory response compared with normoglycemic controls (Naguib et al. 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Naguib et al. 2004
Not checked in the free run.
- Interpretationcitation§ Abstract
Human studies examining the impact of diabetes on the oral microbiome have not provided conclusive evidence for a significant change or no change.
“Thus, human studies examining the impact of diabetes in the oral microbiome have not provided conclusive evidence for a significant change or no change.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
Type 1 and type 2 diabetes mellitus increase the inflammatory response to the same bacterial challenge.
“T1DM and T2DM increase the inflammatory response to the same bacterial challenge (Naguib et al. 2004; Graves et al. 2005).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Naguib et al. 2004
Not checked in the free run.
- cites Graves et al. 2005
Not checked in the free run.
- Interpretationreasoning§ Abstract
There is no consensus that type 1 diabetes mellitus induces a specific bacterial change as compared with type 2 diabetes mellitus.
“Similarly, there is no consensus that T1DM induces a specific bacterial change as compared with T2DM.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
Diabetes affects mesenchymal cells in the host, including periodontal ligament cells, osteoblasts, and osteocytes, that increase RANKL expression and reduce coupled bone formation following an episode of periodontal bone loss.
“Diabetes also affects mesenchymal cells in the host, including periodontal ligament cells, osteoblasts, and osteocytes that increase RANKL expression, and reduce coupled bone formation following an episode of periodontal bone loss (Wu et al. 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wu et al. 2015
Not checked in the free run.
- Interpretationcitation§ Abstract
Controlling inflammation increases the likelihood of having a "nonpathogenic" oral bacterial profile.
“suggesting that controlling inflammation increases the likelihood of having a “nonpathogenic” oral bacterial profile”
Quote in the paperSubstantial claim - Interpretationreasoning§ Abstract
Inhibition of IL-17 could alter the microbiota by reducing inflammation, which in turn affects bacterial growth or colonization.
“Inhibition of IL-17 could alter the microbiota by reducing inflammation, which in turn affects bacterial growth or colonization.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
Oral administration of P. gingivalis coincides with the development of systemic inflammation and onset of insulin resistance in mice.
“Oral administration of P. gingivalis coincides with the development of systemic inflammation and onset of insulin resistance in mice (Arimatsu et al. 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Arimatsu et al. 2014 source
Not checked in the free run.
- Premisecitation§ Abstract
Rheumatoid arthritis in rodents increases the expression of inflammatory cytokines in the periodontium, such as tumor necrosis factor-alpha, IL-1, IL-6, and IL-17.
“RA in rodents increases the expression of inflammatory cytokines in the periodontium, such as TNF-α, IL-1, IL-6, and IL-17 (Queiroz-Junior et al. 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Queiroz-Junior et al. 2011
Not checked in the free run.
- Interpretationcitation§ Abstract
Rheumatoid arthritis alters the oral microbiome qualitatively and quantitatively in animal studies.
“RA alters the oral microbiome qualitatively and quantitatively in animal studies.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Corrêa et al. 2016
Not checked in the free run.
- Premisecitation§ Abstract
Mice with rheumatoid arthritis exhibit higher levels of Parvimonas micra, Selenomonas noxia, and Veionella parvula.
“Mice with RA exhibit higher levels of Parvimonas micra, Selenomonas noxia, and Veionella parvula (Corrêa et al. 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Corrêa et al. 2016
Not checked in the free run.
- Premisecitation§ Abstract
Chronic systemic inflammation in rheumatoid arthritis may affect levels of inflammatory cytokines in oral tissues.
“Chronic systemic inflammation in RA may affect levels of inflammatory cytokines in oral tissues (Mirrielees et al. 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mirrielees et al. 2010
Not checked in the free run.
- Premisecitation§ Abstract
Increased prevalence of periodontitis is observed in patients with rheumatoid arthritis.
“Increased prevalence of periodontitis is observed in patients with RA (de Smit et al. 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites de Smit et al. 2015
Not checked in the free run.
- Premisecitation§ Abstract
Studies examining other diseases showed a link between IL-17 and disturbances in the microbiota, such as leukocyte adhesion deficiency 1 and oral lichen planus.
“It is noteworthy that studies examining other diseases showed a link between IL-17 and disturbances in the microbiota, such as LAD-1 (leukocyte adhesion deficiency 1) and oral lichen planus (Moutsopoulos et al. 2014; Wang et al. 2014).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Moutsopoulos et al. 2014
Not checked in the free run.
- cites Wang et al. 2014
Not checked in the free run.
- Premisecitation§ Abstract
Experimental arthritis in rodents promotes alveolar bone loss.
“We and others have shown that experimental arthritis in rodents promotes alveolar bone loss (Ramamurthy et al. 2005; Queiroz-Junior et al. 2011; Corrêa et al. 2016; Kim et al. 2017).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Ramamurthy et al. 2005
Not checked in the free run.
- cites Queiroz-Junior et al. 2011
Not checked in the free run.
- cites Corrêa et al. 2016
Not checked in the free run.
- Premisecitation§ Abstract
Periodontitis can initiate rheumatoid arthritis by the production of enzymes that form malondialdehyde-acetaldehyde, citrullinated and carbamylated adducts that enhance self-antigenicity to initiate an autoimmune response.
“There is also evidence that periodontitis can initiate RA by the production of enzymes that form malondialdehyde-acetaldehyde, citrullinated and carbamylated adducts that enhance self-antigenicity to initiate an autoimmune response (de Smit et al. 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites de Smit et al. 2015
Not checked in the free run.
- Interpretationreasoning§ Abstract
The data are consistent with a "2-hit" model, in which one hit represents the oral microbiota and the second hit the impact of the systemic disease on the local inflammation.
“The data are consistent with a “2-hit” model, in which one hit represents the oral microbiota and the second hit the impact of the systemic disease on the local inflammation.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
Periodontal disease and rheumatoid arthritis share some pathogenic mechanisms, including enhanced inflammation and bone loss.
“Periodontal disease and RA share some pathogenic mechanisms, including enhanced inflammation and bone loss.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites de Smit et al. 2015
Not checked in the free run.
- Premisecitation§ Abstract
In humans, the rheumatoid arthritis-associated microbiome is substantially different from that of healthy controls.
“In humans, the RA-associated microbiome is substantially different from that of healthy controls.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Scher et al. 2012
Not checked in the free run.
- cites Zhang et al. 2015
Not checked in the free run.
- Interpretationcitation§ Abstract
Increased levels of inflammatory mediators in periodontal tissues of subjects with RA and other diseases may change ecologic conditions to favor pathogenic bacterial species and promote periodontitis.
“The increased levels of inflammatory mediators in the periodontal tissues of subjects with RA and other diseases may change the ecologic conditions to favor pathogenic bacterial species and promote periodontitis (Abusleme and Moutsopoulos 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Abusleme and Moutsopoulos 2017
Not checked in the free run.
- Premisecitation§ Abstract
Prevotella maculosa, associated with oral health, is increased after RA treatment.
“For example, bacteria that are associated with oral health as Prevotella maculosa are increased after RA treatment.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhang et al. 2015
Not checked in the free run.
- Premisecitation§ Abstract
Inflamed subgingival sites exhibit a low redox potential.
“Inflamed subgingival sites, which exhibit a low redox potential, support a microbial community with higher proportions of obligate anaerobic bacteria (Dewhirst 2010; Diaz 2012; Griffen et al. 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Dewhirst 2010
Not checked in the free run.
- cites Diaz 2012
Not checked in the free run.
- cites Griffen et al. 2012
Not checked in the free run.
- Premisecitation§ Abstract
Prevotella species are enriched in the saliva and subgingival microbiota of rheumatoid arthritis subjects.
“Similarly, Prevotella species are also enriched in the saliva (Zhang et al. 2015) and subgingival microbiota (Corrêa et al. 2018, unpublished) of RA subjects.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Zhang et al. 2015
Not checked in the free run.
- cites Corrêa et al. 2018, unpublished
Not checked in the free run.
- Interpretationreasoning§ Abstract
Local inflammation enhanced by systemic disease may change the microbial composition toward one adapted to an inflammatory environment and more capable of inducing inflammation.
“Local inflammation enhanced by systemic disease may change the microbial composition toward one that is adapted to an inflammatory environment and more capable of inducing inflammation.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
Inflamed subgingival sites support a microbial community with higher proportions of obligate anaerobic bacteria.
“Inflamed subgingival sites, which exhibit a low redox potential, support a microbial community with higher proportions of obligate anaerobic bacteria (Dewhirst 2010; Diaz 2012; Griffen et al. 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Dewhirst 2010
Not checked in the free run.
- cites Diaz 2012
Not checked in the free run.
- cites Griffen et al. 2012
Not checked in the free run.
- Premisecitation§ Abstract
Functional studies linking specific microbiota disturbances and inflammatory pathways with periodontal damage in SLE have not been reported.
“However, functional studies linking specific microbiota disturbances and inflammatory pathways with periodontal damage in SLE have not been reported as they have been for diabetes (Xiao 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Xiao 2017
Not checked in the free run.
- Premisenone given§ Abstract
Inflammatory changes are linked to dysbiosis of the subgingival biofilm in SLE subjects.
“The inflammatory changes have been linked to dysbiosis of the subgingival biofilm in SLE subjects, as described in Figure 1.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Figure 1
Not checked in the free run.
- Premisecitation§ Abstract
SLE subjects have a 1.76-fold increased risk of periodontal disease.
“In a meta-analysis, a 1.76-fold increased risk of periodontal disease in SLE subjects was reported (Rutter-Locher et al. 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rutter-Locher et al. 2017
Not checked in the free run.
- Premisecitation§ Abstract
SLE patients have a higher bacterial load compared with healthy subjects.
“It was demonstrated that SLE patients have a higher bacterial load as compared with healthy subjects (Jensen et al. 1999; Corrêa et al. 2017) with an altered bacterial composition.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Jensen et al. 1999
Not checked in the free run.
- cites Corrêa et al. 2017
Not checked in the free run.
- Premisecitation§ Abstract
SLE is associated with increased periodontal disease.
“In the oral cavity, the manifestations of SLE include unspecified oral ulcers (Jensen et al. 1999), xerostomia, hyposalivation (Jensen et al. 1999), and increased periodontal disease (Mutlu et al. 1993; Kobayashi et al. 2003; Corrêa et al. 2017).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Mutlu et al. 1993
Not checked in the free run.
- cites Kobayashi et al. 2003
Not checked in the free run.
- cites Corrêa et al. 2017
Not checked in the free run.
- Premisecitation§ Abstract
SLE is linked to microbial dysbiosis.
“The etiology of SLE includes genetic and environmental factors (López et al. 2016) and is linked to microbial dysbiosis (Hevia et al. 2014; López et al. 2016; Corrêa et al. 2017).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Hevia et al. 2014
Not checked in the free run.
- cites López et al. 2016
Not checked in the free run.
- cites Corrêa et al. 2017
Not checked in the free run.
- Premisecitation§ Abstract
SLE patients have an altered bacterial composition compared with healthy subjects.
“It was demonstrated that SLE patients have a higher bacterial load as compared with healthy subjects (Jensen et al. 1999; Corrêa et al. 2017) with an altered bacterial composition.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Jensen et al. 1999
Not checked in the free run.
- cites Corrêa et al. 2017
Not checked in the free run.
- Premisecitation§ Abstract
In SLE, presence of pathogenic bacteria is positively correlated with systemic inflammation measured by serum C-reactive protein.
“Moreover, the presence of pathogenic bacteria is positively correlated with the level of systemic inflammation, measured by serum C-reactive protein (Corrêa et al. 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Corrêa et al. 2017
Not checked in the free run.
- Interpretationreasoning§ Concluding Remarks
These changes may enhance pathogenicity of microbiota to further activation of inflammatory pathways.
“These changes may then enhance the pathogenicity of the microbiota to further activation of the inflammatory pathways.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Abstract
Reduced inflammation will promote formation of a less pathogenic oral microbial profile in SLE.
“Taken together, these data highlight the connection between the microbiota and SLE and suggest that reduced inflammation will promote the formation of a less pathogenic oral microbial profile.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
Periodontal health-associated bacteria (Capnocytophaga, Rothia, Haemophilus parainfluenzae, Streptococcus) are diminished in SLE patients with periodontitis.
“In addition, bacteria commonly associated with periodontal health, such as Capnocytophaga, Rothia, Haemophilus parainfluenzae, and Streptococcus, are diminished in SLE patients with periodontitis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Corrêa et al. 2017
Not checked in the free run.
- Interpretationreasoning§ Concluding Remarks
The assumption that increased periodontal inflammation is due to straightforward upregulation of pro-osteoclastogenic factors may be an oversimplification.
“However, this may be an oversimplification, as the inflammatory changes may induce an amplification loop in which the bacterial component becomes more pathogenic.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Concluding Remarks
Host response to oral bacteria may be altered by systemic diseases (diabetes, RA, SLE, LAD-1) so that degree of inflammation induced is greater than in normal conditions.
“For example, the host response to oral bacteria may be altered by systemic diseases such as diabetes, RA, SLE, and LAD-1 so that the degree of inflammation induced is greater than it would be in normal conditions.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
High counts of Lactobacilli and Candida albicans are found in the oral cavity of SLE patients versus controls.
“High counts of Lactobacilli and Candida albicans are found in the oral cavity of SLE patients versus controls (Jensen et al. 1999).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Jensen et al. 1999
Not checked in the free run.
- Premisecitation§ Abstract
SLE patients have changes in gut microbiome reflected by increased diversity compared with healthy individuals.
“Changes in the gut microbiome in SLE patients have been reported and are reflected by increased diversity compared with healthy individuals (Hevia et al. 2014; López et al. 2016).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Hevia et al. 2014
Not checked in the free run.
- cites López et al. 2016
Not checked in the free run.
- Premisecitation§ Abstract
Periodontal treatment improves response to conventional therapy in SLE patients with a reduction of disease activity.
“In line with these findings, periodontal treatment improves the response to conventional therapy in SLE patients with a reduction of disease activity (Fabbri et al. 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fabbri et al. 2014
Not checked in the free run.
- Interpretationreasoning§ Abstract
Changes in microbiota might amplify local inflammation and periodontal tissue damage, worsening impact of systemic disease on periodontal health.
“In turn, changes in the microbiota might be important to amplify local inflammation and periodontal tissue damage, worsening the impact of the systemic disease on periodontal health.”
Quote in the paperSubstantial claim - Premisecitation§ Abstract
Periodontal disease-associated bacteria (Prevotella oulorum, P. nigrescens, P. oris, S noxia, Leptotrichia, Lachnospiraceae) are elevated in SLE subjects, even in periodontally healthy sites.
“Bacteria associated with periodontal disease, including Prevotella oulorum, P. nigrescens, P. oris, S noxia, Leptotrichia, and Lachnospiraceae, are elevated in SLE subjects, even in periodontally healthy sites (Corrêa et al. 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Corrêa et al. 2017
Not checked in the free run.
- Premisecitation§ Abstract
Relative abundance of Lactobacillales seems restored in SLE patients without active disease.
“In line with these results, the relative abundance of Lactobacillales seems to be restored in SLE patients without active disease (Hevia et al. 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hevia et al. 2014
Not checked in the free run.
- Premisecitation§ Abstract
Worsening periodontal condition is correlated with systemic inflammation in SLE.
“Overall, a worsening periodontal condition is correlated with systemic inflammation (Corrêa et al. 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Corrêa et al. 2017
Not checked in the free run.
- Interpretationnone given§ Concluding Remarks
Systemic diseases may share common risk factors that lead to increased inflammatory response when there is an interruption in equilibrium.
“Systemic diseases may share common risk factors that lead to an increased inflammatory response when there is an interruption in equilibrium.”
Quote in the paperNot a substantial claim - Interpretationreasoning§ Concluding Remarks
Local periodontal inflammation may alter competition among bacterial species by affecting nutrient availability or redox potential and/or altering gene expression within a bacterial community.
“The local periodontal inflammation may in turn alter the competition among bacterial species by affecting nutrient availability or redox potential and/or altering gene expression within a bacterial community.”
Quote in the paperNot a substantial claim - Interpretationreasoning§ Concluding Remarks
Overall dysregulation of inflammatory mediators may contribute to host alterations that lead to microbial dysbiosis.
“We also recognize that IL-17 operates in concert with other inflammatory cytokines and that an overall dysregulation of these mediators may contribute to host alterations that lead to microbial dysbiosis.”
Quote in the paperSubstantial claim
- May combine two claims. 49
- Classified as probably not a substantial claim. 9
May combine two claims.
Findingcitation§ AbstractDevelopment of hyperglycemia induced a shift in the bacterial composition, increasing the levels of Proteobacteria (Enterobacteriaceae) and Firmicutes (Enterococcus, Staphylococcus, and Aerococcus) associated with pathologic changes.
“Development of hyperglycemia induced a shift in the bacterial composition (Xiao et al. 2017), increasing the levels of Proteobacteria (Enterobacteriaceae) and Firmicutes (Enterococcus, Staphylo-coccus, and Aerococcus) associated with pathologic changes (Demmer et al. 2016; Grice et al. 2010).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Xiao et al. 2017
Not checked in the free run.
- cites Demmer et al. 2016
Not checked in the free run.
- cites Grice et al. 2010
Not checked in the free run.
- Rests on an assumption: Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
May combine two claims.
Findingcitation§ AbstractTransfer from hyperglycemic mice stimulated greater neutrophil infiltration and increased expression of bone-resorbing cytokines (IL-6 and RANKL), enhanced osteoclast numbers, and stimulated more periodontal bone loss than bacteria from normoglycemic controls.
“Transfer from hyperglycemic mice stimulated greater neutrophil infiltration and increased expression of bone-resorbing cytokines (IL-6 and RANKL), enhanced osteoclast numbers, and stimulated more periodontal bone loss than bacteria from normoglycemic controls.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xiao et al. 2017
Not checked in the free run.
- Rests on an assumption: Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
May combine two claims.
Findingcitation§ AbstractWhen IL-17 was inhibited, the oral microbiota shifted in a direction of reduced pathogenicity and to a composition that was more similar to that of normoglycemic control animals.
“Moreover, when IL-17 was inhibited, the oral microbiota shifted in a direction of reduced pathogenicity and to a composition that was more similar to that of normoglycemic control animals (Xiao et al. 2017), suggesting that controlling inflammation increases the likelihood of having a “nonpathogenic” oral bacterial profile.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xiao et al. 2017
Not checked in the free run.
- Rests on an assumption: Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
May combine two claims.
Findingown data§ AbstractInhibition of IL-17 altered the microbial composition in diabetic mice so that it was more similar to the normoglycemic oral microbiota and reduced the abundance of Enterococcus in particular.
“Inhibition of IL-17 altered the microbial composition in diabetic mice so that it was more similar to the normoglycemic oral microbiota and reduced the abundance of Enterococcus in particular.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xiao et al. 2017
Not checked in the free run.
- Rests on an assumption: Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
May combine two claims.
Findingcitation§ AbstractAging in mice reduces oral bacterial diversity, accompanied by greater colonization of P. gingivalis when exposed to this human pathogen.
“Interestingly, we have found that aging in mice also reduces oral bacterial diversity, which is accompanied by greater colonization of P. gingivalis when exposed to this human pathogen (Xiao et al. 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Xiao et al. 2016
Not checked in the free run.
- Rests on an assumption: Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
May combine two claims.
Findingcitation§ AbstractRheumatoid arthritis subjects show increased salivary concentration of IL-17, tumor necrosis factor-alpha, and IL-33, similar to observations in systemic lupus erythematosus.
“RA subjects also show increased salivary concentration of IL-17, TNF-α, and IL-33 (Corrêa et al. 2018, unpublished results) similar to observations in SLE (Corrêa et al. 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Corrêa et al. 2018, unpublished results
Not checked in the free run.
- cites Corrêa et al. 2017
Not checked in the free run.
May combine two claims.
Findingcitation§ AbstractRheumatoid arthritis increases the microbial biomass approximately 1-log and alters the composition with increased numbers of pathogenic bacteria.
“We also found that RA increases the microbial biomass approximately 1-log and alters the composition with increased numbers of pathogenic bacteria (Corrêa et al. 2018, unpublished results).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Corrêa et al. 2018, unpublished results
Not checked in the free run.
May combine two claims.
Interpretationnone given§ AbstractAll three systemic diseases (diabetes, rheumatoid arthritis, and systemic lupus erythematosus) are linked to a decrease in bacterial taxa associated with health and an increase in taxa associated with disease.
“All 3 systemic diseases are linked to a decrease in bacterial taxa associated with health and an increase in taxa associated with disease.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationcitation§ AbstractIncreased IL-17 has been shown in systemic lupus erythematosus, rheumatoid arthritis, and leukocyte adhesion deficiency and may contribute to oral microbial changes in these diseases.
“Increased IL-17 has also been shown in SLE, RA, and leukocyte adhesion deficiency and may contribute to oral microbial changes in these diseases.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abusleme and Moutsopoulos 2017
Not checked in the free run.
May combine two claims.
Interpretationreasoning§ AbstractIncreased levels of periodontal disease, diabetes, systemic lupus erythematosus, and rheumatoid arthritis may reflect a common susceptibility, since each has inflammation as a common risk factor.
“Increased levels of periodontal disease, diabetes, systemic lupus erythematosus (SLE), and RA may reflect a common susceptibility, since each has inflammation as a common risk factor.”
Quote in the paperSubstantial claimMay combine two claims.
Premisereasoning§ AbstractThe composition of the microbiota is governed by local factors, but systemic factors can also have a significant effect.
“The composition of the microbiota is governed by local factors, but systemic factors can also have a significant effect.”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitation§ AbstractIncreased bacterial loads occur in humans with periodontitis and in mice as they age and develop periodontitis, with increased susceptibility to colonization by periodontal pathogens such as P. gingivalis.
“This is supported by increased bacterial loads in humans with periodontitis and in mice as they age and develop periodontitis, with increased susceptibility to colonization by periodontal pathogens such as P. gingivalis (Wu et al. 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wu et al. 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing).
Interpretationcitation§ AbstractAn overall increase in microbial biomass, rather than a specific change in composition, may promote periodontitis.
“An alternative hypothesis that was popular in the mid-1900s and has some recent support postulates that an overall increase in microbial biomass, rather than a specific change in composition, may promote periodontitis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wu et al. 2016
Not checked in the free run.
May combine two claims.
Interpretationreasoning§ AbstractIndividuals with a greater tendency toward inflammation have enhanced susceptibility and risk of periodontitis as well as increased levels of diabetes, systemic lupus erythematosus, and rheumatoid arthritis.
“Those individuals with a greater tendency toward inflammation have enhanced susceptibility and risk of periodontitis as well as increased levels of diabetes, SLE, and RA.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationreasoning§ AbstractSystemic inflammatory diseases may increase local inflammation, which alters the expression of inflammatory mediators locally and increases recruitment of leukocytes to the periodontium.
“One mechanism is that systemic inflammatory diseases may increase local inflammation, which alters the expression of inflammatory mediators locally and increases recruitment of leukocytes to the periodontium (see Fig. 1).”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitation§ AbstractQualitative changes occur as a result of competitiveness among species, leading to an increase in bacterial taxa that are pathogenic.
“Qualitative changes also occur as a result of competitiveness among species (Diaz 2012; Griffen et al. 2012), leading to an increase in bacterial taxa that are pathogenic.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Diaz 2012
Not checked in the free run.
- cites Griffen et al. 2012
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractDiabetes potentially affects factors that can enhance inflammation in periodontal tissues, including high glucose levels, increased formation of advanced glycation end products, and enhanced cytokine expression (e.g., tumor necrosis factor).
“Diabetes potentially affects a number of factors that can enhance inflammation in periodontal tissues, including high glucose levels, increased formation of advanced glycation end products, and enhanced cytokine expression (e.g., tumor necrosis factor [TNF]; Wu et al. 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wu et al. 2015
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractNeutrophils and monocytes/macrophages from diabetic patients express higher levels of cytokines in response to stimulation and are less effective in bacterial killing.
“Neutrophils and monocytes/macrophages from diabetic patients express higher levels of cytokines in response to stimulation and are less effective in bacterial killing (Omori et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Omori et al. 2008
Not checked in the free run.
Classified as probably not a substantial claim.
Premisecitation§ AbstractA consensus report from the European Federation of Periodontology and the American Academy of Periodontology found no compelling evidence that diabetes has a significant impact on the oral microbiota.
“A consensus report from the European Federation of Periodontology and the American Academy of Periodontology found no compelling evidence that diabetes has a significant impact on the oral microbiota (Chapple et al. 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chapple et al. 2013
Not checked in the free run.
May combine two claims.
Interpretationcitation§ AbstractRecent high-throughput analysis suggests that there may be differences between diabetic and normal cohorts, but there is yet no consensus on the changes induced.
“Recent high-throughput analysis suggests that there may be differences between diabetic and normal cohorts, but there is yet no consensus on the changes induced, as shown in Table 1 (Casarin et al. 2012; Aemaimanan et al. 2013; Zhou et al. 2013; Merchant et al. 2014; Sakalauskiene et al. 2014; Castrillon et al. 2015; Demmer et al. 2016).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Casarin et al. 2012
Not checked in the free run.
- cites Aemaimanan et al. 2013
Not checked in the free run.
- cites Zhou et al. 2013
Not checked in the free run.
May combine two claims.
Interpretationreasoning§ AbstractPrevious human studies have not revealed consistent changes in microbial composition, in part because of the limited numbers of bacteria surveyed.
“Thus, previous human studies have not revealed consistent changes in microbial composition, in part because of the limited numbers of bacteria surveyed.”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitation§ AbstractType 1 and type 2 diabetes mellitus affect the periodontium in children and adults, with an increase in periodontal inflammation similar to the increased inflammation in other tissues affected by diabetes.
“Type 1 and type 2 diabetes mellitus (T1DM and T2DM) affect the periodontium in children and adults, with an increase in periodontal inflammation similar to the increased inflammation in other tissues affected by diabetes (Wu et al. 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wu et al. 2015
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractIn skin wounds, diabetes alters the wound microbiota, which is linked to increased inflammation.
“In skin wounds, diabetes alters the wound microbiota, which is linked to increased inflammation (Grice et al. 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Grice et al. 2010
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractHigh IL-17 levels are found in humans with periodontitis, and IL-17 induces RANKL.
“Interestingly, high IL-17 levels are found in humans with periodontitis, and IL-17 induces RANKL (Abusleme and Moutsopoulos 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Abusleme and Moutsopoulos 2017
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractButyrate-producing bacteria are reduced in individuals with type 2 diabetes mellitus, and butyrate protects against the development of diabetes; thus, reduced production of butyrate may increase risk of diabetes.
“Butyrate-producing bacteria are reduced in individuals with T2DM, and butyrate protects against the development of diabetes (Arora and Bäckhed 2016); thus, reduced production of butyrate may increase risk of diabetes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Arora and Bäckhed 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ AbstractRheumatoid arthritis is a systemic autoimmune disease characterized by chronic inflammation.
“RA is a systemic autoimmune disease characterized by chronic inflammation (de Smit et al. 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites de Smit et al. 2015
Not checked in the free run.
May combine two claims.
Interpretationown data§ AbstractChronic inflammation enhanced by diabetes causes microbial dysbiosis that increases bacterial pathogenicity.
“We propose that chronic inflammation enhanced by diabetes causes microbial dysbiosis that increases bacterial pathogenicity (see Fig. 2).”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitation§ AbstractLeukocyte adhesion deficiency in humans results in greater IL-17 production and formation of dysbiotic bacterial communities, thereby identifying IL-17 as a cause of microbial dysbiosis.
“Leukocyte adhesion deficiency in humans results in greater IL-17 production and formation of dysbiotic bacterial communities, thereby identifying IL-17 as a cause of microbial dysbiosis (Abusleme and Moutsopoulos 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Abusleme and Moutsopoulos 2017
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractPatients with oral lichen planus have increased disease-associated bacterial species and increased IL-17 in saliva.
“Similarly, patients with oral lichen planus have increased disease-associated bacterial species and increased IL-17 in saliva (Wang et al. 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wang et al. 2014
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractThe gut microbiota changes with diabetes, which is subsequently altered when diabetes is reversed by bariatric surgery.
“Similarly, the gut microbiota changes with diabetes, which is subsequently altered when diabetes is reversed by bariatric surgery (Sweeney and Morton 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sweeney and Morton 2013
Not checked in the free run.
May combine two claims.
Interpretationcitation§ AbstractOral bacteria may contribute to a bidirectional relationship between periodontal disease and diabetes, whereby changes in the oral microbiota through increased systemic inflammation enhance insulin resistance to promote hyperglycemia.
“Oral bacteria may contribute to a bidirectional relationship between periodontal disease and diabetes, whereby changes in the oral microbiota through increased systemic inflammation enhance insulin resistance to promote hyperglycemia (as discussed by Borgnakke et al. 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Borgnakke et al. 2013
Not checked in the free run.
May combine two claims.
Interpretationnone given§ AbstractOral bacteria may also have an impact on diabetes, although the evidence to support this link is limited.
“Oral bacteria may also have an impact on diabetes, although the evidence to support this link is limited.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationcitation§ AbstractThere may be a bidirectional relationship between the gut microbiota and diabetes whereby diabetes alters bacterial composition and changes in bacterial profile enhance susceptibility to diabetes through a butyrate-mediated mechanism.
“Furthermore, there may be a bidirectional relationship between the gut microbiota and diabetes whereby 1) diabetes alters bacterial composition and 2) changes in bacterial profile enhance susceptibility to diabetes through a butyrate-mediated mechanism.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ AbstractTreatment with oral antiseptics that reduce the total oral bacterial load protects against rheumatoid arthritis-induced periodontal bone loss, indicating a role for oral microbiota.
“Treatment with oral antiseptics that reduce the total oral bacterial load protects against RA-induced periodontal bone loss, indicating a role for oral microbiota (Queiroz-Junior et al. 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Queiroz-Junior et al. 2011
Not checked in the free run.
May combine two claims.
Interpretationcitation§ AbstractRheumatoid arthritis may amplify the inflammatory response in the periodontium, which in turn modifies the microbiota.
“RA may amplify the inflammatory response in the periodontium, which in turn modifies the microbiota (Golub et al. 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Golub et al. 2006
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractAnaerobic species such as Lactobacillus salivarius, Atopobium, Leptotrichia, Prevotella, and Cryptobacterium curtum are enriched in the oral microbiota of rheumatoid arthritis patients, and health-associated Corynebacterium and Streptococcus genera are reduced.
“Anaerobic species such as Lactobacillus salivarius, Atopobium, Leptotrichia, Prevotella, and Cryptobacterium curtum are enriched in the oral microbiota of RA patients, and health-associated Corynebacterium and Streptococcus genera are reduced (Scher et al. 2012; Zhang et al. 2015).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Scher et al. 2012
Not checked in the free run.
- cites Zhang et al. 2015
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractDisease-modifying antirheumatic drugs reduce inflammation and severity of RA, and alter gut and oral microbiota.
“Disease-modifying antirheumatic drugs reduce inflammation and the severity of RA, and alter the gut and oral microbiota (Zhang et al. 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhang et al. 2015
Not checked in the free run.
May combine two claims.
Interpretationreasoning§ AbstractIn RA, increased inflammation coupled with microbial changes may amplify periodontal inflammation and explain greater susceptibility to periodontitis.
“The increased inflammation caused by RA coupled with microbial changes may amplify periodontal inflammation and explain the greater susceptibility to periodontitis that we and others have observed in these patients (de Smit et al. 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites de Smit et al. 2015
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractPrevotella copri has a high capacity to induce Th17-related cytokines, and Prevotella sp. is associated with Th17-mediated mucosal inflammation.
“Interestingly, Prevotella copri has a high capacity to induce Th17-related cytokines, and Prevotella sp. is associated with Th17-mediated mucosal inflammation (Larsen 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Larsen 2017
Not checked in the free run.
May combine two claims.
Interpretationreasoning§ AbstractChanges in systemic and local inflammation may disrupt microbial homeostasis and consequently increase bacterial pathogenicity and periodontal disease susceptibility.
“Therefore, changes in systemic and local inflammation may disrupt microbial homeostasis and consequently increase bacterial pathogenicity and periodontal disease susceptibility (see Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractThe microbial composition of the gut in early rheumatoid arthritis differs from controls, with a reduction of Bifidobacterium and Bacteroides and an increase in Prevotella.
“The microbial composition of the gut in early RA differs from controls, with a reduction of Bifidobacterium and Bacteroides and an increase in Prevotella (Horta-Baas et al. 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Horta-Baas et al. 2017
Not checked in the free run.
May combine two claims.
Interpretationreasoning§ AbstractControlling inflammation can shift the microbiota to a healthy status, restoring systemic and oral/periodontal homeostasis.
“These results suggest that controlling inflammation can shift the microbiota to a “healthy status,” restoring systemic and oral/periodontal homeostasis.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhang et al. 2015
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractRA treatment improves periodontal status and affects the oral microbiome.
“Conversely, RA treatment improves periodontal status and affects the oral microbiome (Zhang et al. 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhang et al. 2015
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractIncreased periodontal disease risk in SLE is associated with changes in local and systemic inflammatory pathways, demonstrated by elevated salivary cytokines (IL-6, IL-17, IL-33).
“The increased risk is associated with changes in local and systemic inflammatory pathways, as demonstrated by elevated levels of cytokines (e.g., IL-6, IL-17, and IL-33) in the saliva of SLE patients (Marques et al. 2016; Corrêa et al. 2017; Mendonça et al. 2018).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Marques et al. 2016
Not checked in the free run.
- cites Corrêa et al. 2017
Not checked in the free run.
- cites Mendonça et al. 2018
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractOral manifestations of SLE include unspecified oral ulcers, xerostomia, and hyposalivation.
“In the oral cavity, the manifestations of SLE include unspecified oral ulcers (Jensen et al. 1999), xerostomia, hyposalivation (Jensen et al. 1999), and increased periodontal disease (Mutlu et al. 1993; Kobayashi et al. 2003; Corrêa et al. 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jensen et al. 1999
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ AbstractSLE etiology includes genetic and environmental factors.
“The etiology of SLE includes genetic and environmental factors (López et al. 2016) and is linked to microbial dysbiosis (Hevia et al. 2014; López et al. 2016; Corrêa et al. 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites López et al. 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ Concluding RemarksSeveral systemic diseases cause increased periodontal inflammation with the assumption that primary component was straightforward upregulation of pro-osteoclastogenic factors.
“Furthermore, it is widely recognized that several systemic diseases cause increased periodontal inflammation with the assumption that the primary component was a straightforward upregulation of pro-osteoclastogenic factors (Xiao et al. 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Xiao et al. 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.
Interpretationcitation§ Concluding RemarksAssignment to good and bad categories is an oversimplification and needs experimental justification.
“However, the assignment to “good” and “bad” categories is an oversimplification and needs to be experimentally justified, as recently reported for murine diabetic studies (Xiao et al. 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Xiao et al. 2017
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractSLE subjects have reduced microbial diversity with greater proportions of pathogenic bacteria.
“SLE subjects have reduced microbial diversity with greater proportions of pathogenic bacteria (Corrêa et al. 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Corrêa et al. 2017
Not checked in the free run.
May combine two claims.
Premisecitation§ AbstractLupus-prone mice have depleted lactobacilli and increased Clostridial species (Lachnospiraceae) associated with overall increased bacterial diversity.
“Lupus-prone mice have depleted lactobacilli and an increase in Clostridial species (Lachnospiraceae) associated with an overall increase in bacterial diversity (Zhang et al. 2014; Mu et al. 2017).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Zhang et al. 2014
Not checked in the free run.
- cites Mu et al. 2017
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationreasoning§ Concluding RemarksIL-17 and other cytokines may play a pivotal role in this process.
“IL-17 and other cytokines may play a pivotal role in this process.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ AbstractIncreasing Lactobacillales in the gut of mice by adding a mixture of 5 Lactobacillus strains improved SLE severity and prolonged survival.
“As a proof of concept, increasing Lactobacillales in the gut of mice by adding a mixture of 5 Lactobacillus strains led to an improvement of SLE severity and prolonged survival (Mu et al. 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mu et al. 2017
Not checked in the free run.
May combine two claims.
Interpretationcitation§ AbstractIncreased inflammation may provide nutrients in the form of tissue breakdown products and alter the environment, favoring growth of anaerobic bacteria.
“Increased inflammation may provide a source of nutrients in the form of tissue breakdown products and may alter the environment, favoring the growth of anaerobic bacteria (Hajishengallis 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hajishengallis 2014
Not checked in the free run.
May combine two claims.
Interpretationreasoning§ Concluding RemarksMicrobial changes observed in systemic diseases generally reduce microbial diversity and shift bacterial composition by increasing taxa considered bad and reducing those considered good.
“Microbial changes observed in systemic diseases generally reduce microbial diversity and shift bacterial composition by increasing taxa that are generally considered to be “bad” and reducing those that are “good” (see Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone given§ Concluding RemarksInflammatory changes may induce an amplification loop in which the bacterial component becomes more pathogenic.
“However, this may be an oversimplification, as the inflammatory changes may induce an amplification loop in which the bacterial component becomes more pathogenic.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone given§ Concluding RemarksIL-17 operates in concert with other inflammatory cytokines.
“We also recognize that IL-17 operates in concert with other inflammatory cytokines and that an overall dysregulation of these mediators may contribute to host alterations that lead to microbial dysbiosis.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Findings from animal models of diabetes, rheumatoid arthritis, and systemic lupus erythematosus are representative of the corresponding human systemic diseases for the purpose of inferring effects on the human oral microbiota.
“In an animal model, diabetes increased the pathogenicity of the oral microbiome, as shown by increased inflammation, osteoclastogenesis, and periodontal bone loss when transferred to normal germ-free hosts.”
“Together, these data demonstrate that systemic diseases characterized by enhanced inflammation disturb the oral microbiota and point to IL-17 as key mediator in this process.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The decrease in oral microbiota diversity in diabetes is associated with an increase in the pathogenic content of the hyperglycemic microbiota, such as Capnocytophaga, Porphyromonas, and Pseudomonas.
“Moreover, it has been reported that the diversity of oral microbiota in patients with diabetes decreases significantly, and is associated with an increase in the pathogenic content of the hyperglycemic microbiota (Saeb et al., 2019), such as Capnocytophaga, Porphyromonas, and Pseudomonas (Graves et al., 2019).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Graves et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Prevotella maculosa is classified as both health- and periodontitis-associated
MinorThe paper calls P. maculosa associated with oral health when describing its increase after RA treatment, but earlier lists it among periodontitis-associated bacteria enriched in RA patients.
“For example, bacteria that are associated with oral health as Prevotella maculosa are increased after RA treatment.”
“RA patients without periodontitis have an enrichment in periodontitis-associated bacteria, such as Prevotella (e.g., P. melaninogenica, P. denticola, P. histicola, P. nigrescens, P. oulorum, and P. maculosa), and other pathogenic species (S. noxia, S. sputigena, and Anaeroglobus geminatus)”
Cites
Microbial complexes in subgingival plaque
Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C., & Kent, R. L. (1998) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.1998.tb02419.x · Cited by 5,050 · see citing works
Dewhirst, F. E., Chen, T., Izard, J., Paster, B. J., Tanner, A. C. R., Yu, W.-H., Lakshmanan, A., & Wade, W. G. (2010) · Journal of Bacteriology · doi:10.1128/jb.00542-10 · Cited by 3,352 · see citing works
Kinane, D. F., Stathopoulou, P. G., & Papapanou, P. N. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.38 · Cited by 2,724 · see citing works
Socransky, S. S., & Haffajee, A. D. (2005) · Periodontology 2000 · doi:10.1111/j.1600-0757.2005.00107.x · Cited by 1,691 · see citing works
Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3914 · Cited by 1,690 · see citing works
Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function
Olszak, T., An, D., Zeissig, S., Vera, M. P., Richter, J., Franke, A., Glickman, J. N., Siebert, R., Baron, R. M., Kasper, D. L., et al. (2012) · Science · doi:10.1126/science.1219328 · Cited by 1,661 · see citing works
The immune response to <i>Prevotella</i> bacteria in chronic inflammatory disease
Larsen, J. M. (2017) · Immunology · doi:10.1111/imm.12760 · Cited by 1,343 · see citing works
Segata, N., Haake, S. K., Mannon, P., Lemon, K. P., Waldron, L., Gevers, D., Huttenhower, C., & Izard, J. (2012) · Genome Biology · doi:10.1186/gb-2012-13-6-r42 · Cited by 1,076 · see citing works
Griffen, A. L., Beall, C. J., Campbell, J. H., Firestone, N. D., Kumar, P., Yang, Z. K., Podar, M., & Leys, E. J. (2011) · The ISME Journal · doi:10.1038/ismej.2011.191 · Cited by 1,006 · see citing works
Chapple, I. L. C., Genco, R., & on behalf of working group 2 of the joint EFP/AAP workshop (2013) · Journal of Periodontology · doi:10.1902/jop.2013.1340011 · Cited by 852 · see citing works
Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus
Hevia, A., Milani, C., López, P., Cuervo, A., Arboleya, S., Duranti, S., Turroni, F., González, S., Suárez, A., Gueimonde, M., et al. (2014) · mBio · doi:10.1128/mbio.01548-14 · Cited by 620 · see citing works
Arimatsu, K., Yamada, H., Miyazawa, H., Minagawa, T., Nakajima, M., Ryder, M. I., Gotoh, K., Motooka, D., Nakamura, S., Iida, T., et al. (2014) · Scientific Reports · doi:10.1038/srep04828 · Cited by 573 · see citing works
Jepsen, S., Caton, J. G., Albandar, J. M., Bissada, N. F., Bouchard, P., Cortellini, P., Demirel, K., de Sanctis, M., Ercoli, C., Fan, J., et al. (2018) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12951 · Cited by 566 · see citing works
Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence
Borgnakke, W. S., Ylöstalo, P., Taylor, G. W., & Genco, R. J. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.1340013 · Cited by 499 · see citing works
Periodontal disease and the oral microbiota in new‐onset rheumatoid arthritis
Scher, J. U., Úbeda, C., Equinda, M. J., Khanin, R., Buischi, Y. D. P., Viale, A. J., Lipuma, L., Attur, M. G., Pillinger, M. H., Weissmann, G., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34539 · Cited by 465 · see citing works
Chapple, I., Genco, R. J., & working group 2 of the joint EFP/AAP workshop (2013) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12077 · Cited by 447 · see citing works
Control of lupus nephritis by changes of gut microbiota
Mu, Q., Zhang, H., Liao, X., Lin, K., Liu, H., Edwards, M. R., Ahmed, S. A., Yuan, R., Li, L., Cecere, T. E., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0300-8 · Cited by 408 · see citing works
The inflammophilic character of the periodontitis-associated microbiota
Hajishengallis, G. (2014) · Molecular Oral Microbiology · doi:10.1111/omi.12065 · Cited by 407 · see citing works
Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity
Xiao, E., Mattos, M., Vieira, G. H. A., Chen, S., Corrêa, J. D., Wu, Y., Albiero, M. L., Bittinger, K., & Graves, D. T. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.014 · Cited by 396 · see citing works
Self-citationBlockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice.
Lalla, E., Lamster, I., Feit, M., Huang, L., Spessot, A., Qu, W., Kislinger, T., Lu, Y., Stern, D. M., & Schmidt, A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8942 · Cited by 362 · see citing works
Horta‐Baas, G., Romero-Figueroa, M. D. S., Montiel-Jarquín, Á. J., Pizano-Zárate, M. L., Garcı́a-Mena, J., & Ramírez‐Durán, N. (2017) · Journal of Immunology Research · doi:10.1155/2017/4835189 · Cited by 328 · see citing works
Diabetes mellitus related bone metabolism and periodontal disease
Wu, Y., Xiao, E., & Graves, D. T. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2015.2 · Cited by 314 · see citing works
Self-citationDynamics of Gut Microbiota in Autoimmune Lupus
Zhang, H., Liao, X., Sparks, J. B., & Luo, X. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.02676-14 · Cited by 305 · see citing works
Moutsopoulos, N. M., Konkel, J. E., Sarmadi, M., Eskan, M. A., Greenwell‐Wild, T., Dutzan, N., Abusleme, L., Zenobia, C., Hosur, K. B., Abe, T., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007696 · Cited by 303 · see citing works
The gut microbiota and metabolic disease: current understanding and future perspectives
Arora, T., & Bäckhed, F. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12508 · Cited by 301 · see citing works
Diabetes and Periodontal Disease: A Case‐Control Study
Campus, G., Salem, A. N., Uzzau, S., Baldoni, E., & Tonolo, G. (2005) · Journal of Periodontology · doi:10.1902/jop.2005.76.3.418 · Cited by 280 · see citing works
López, P., de Paz, B., Rodríguez-Carrio, J., Hevia, A., Sánchez, B., Margolles, A., & Suárez, A. (2016) · Scientific Reports · doi:10.1038/srep24072 · Cited by 262 · see citing works
Subgingival biodiversity in subjects with uncontrolled type‐2 diabetes and chronic periodontitis
Casarin, R. C. V., Barbagallo, A., Meulman, T., Santos, V. R., Sallum, E. A., Nociti, F. H., Duarte, P. M., Casati, M. Z., & Gonçalves, R. B. (2013) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2012.01498.x · Cited by 256 · see citing works
Sweeney, T. E., & Morton, J. M. (2013) · JAMA Surgery · doi:10.1001/jamasurg.2013.5 · Cited by 250 · see citing works
Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response
Grice, E. A., Snitkin, E. S., Yockey, L. J., Bermudez, D. M., Program, N. C. S., Liechty, K. W., Segre, J. A., Mullikin, J., Blakesley, R., Young, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004204107 · Cited by 227 · see citing works
Diabetes Prolongs the Inflammatory Response to a Bacterial Stimulus Through Cytokine Dysregulation
Naguib, G. H., Almashat, H., Desta, T., & Graves, D. T. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22711.x · Cited by 221 · see citing works
Self-citationDistinct fecal and oral microbiota composition in human type 1 diabetes, an observational study
de Groot, P. F., Belzer, C., Aydin, Ö., Levin, E., Levels, J. H. M., Aalvink, S., Boot, F., Holleman, F., van Raalte, D. H., Scheithauer, T. P. M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188475 · Cited by 208 · see citing works
The Relationship of the Oral Microbiotia to Periodontal Health and Disease
Curtis, M. A., Zenobia, C., & Darveau, R. P. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.09.008 · Cited by 205 · see citing works
Sato, K., Takahashi, N., Kato, T., Matsuda, Y., Yokoji, M., Yamada, M., Nakajima, T. E., Kondo, N., Endo, N., Yamamoto, R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07196-7 · Cited by 202 · see citing works
Association of oral microbiome with type 2 diabetes risk
Long, J., Cai, Q., Steinwandel, M. D., Hargreaves, M. K., Bordenstein, S. R., Blot, W. J., Zheng, W., & Shu, X. (2017) · Journal of Periodontal Research · doi:10.1111/jre.12432 · Cited by 200 · see citing works
IL ‐17: overview and role in oral immunity and microbiome
Abusleme, L., & Moutsopoulos, N. M. (2016) · Oral Diseases · doi:10.1111/odi.12598 · Cited by 185 · see citing works
Mashimo, P. A., YAMAMOTO, Y., Slots, J., Park, B. H., & Genco, R. J. (1983) · Journal of Periodontology · doi:10.1902/jop.1983.54.7.420 · Cited by 182 · see citing works
Corrêa, J. D., Calderaro, D. C., Ferreira, G. A., Mendonça, S. M. S., Fernandes, G. D. R., Xiao, E., Teixeira, A. L., Leys, E. J., Graves, D. T., & Silva, T. A. (2017) · Microbiome · doi:10.1186/s40168-017-0252-z · Cited by 167 · see citing works
Self-citationA tale of two risks: smoking, diabetes and the subgingival microbiome
Ganesan, S. M., Joshi, V., Fellows, M. L., Dabdoub, S. M., Nagaraja, H. N., OʼDonnell, B., Deshpande, N. R., & Kumar, P. (2017) · The ISME Journal · doi:10.1038/ismej.2017.73 · Cited by 164 · see citing works
Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome
Ussar, S., Fujisaka, S., & Kahn, C. R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.07.004 · Cited by 157 · see citing works
Roberts, F. A., & Darveau, R. P. (2015) · Periodontology 2000 · doi:10.1111/prd.12087 · Cited by 151 · see citing works
Cellular and Molecular Aspects of Bone Remodeling
Xiao, W., Wang, Y., Pacios, S., Li, S., & Graves, D. T. (2015) · Frontiers of oral physiology/Frontiers of oral biology · doi:10.1159/000351895 · Cited by 149 · see citing works
Self-citationFine, D. H., Markowitz, K., Fairlie, K., Tischio‐Bereski, D., Ferrendiz, J., Furgang, D., Paster, B. J., & Dewhirst, F. E. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00729-13 · Cited by 140 · see citing works
Can Systemic Diseases Co-induce ( Not Just Exacerbate) Periodontitis? A Hypothetical “Two-hit” Model
Golub, L. M., Payne, J. B., Reinhardt, R., & Nieman, G. F. (2006) · Journal of Dental Research · doi:10.1177/154405910608500201 · Cited by 139 · see citing works
Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase
Omori, K., Ohira, T., Uchida, Y., Ayilavarapu, S., Júnior, E. L. B., Yagi, M., Iwata, T., Liu, H., Hastürk, H., Kantarcı, A., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1207832 · Cited by 139 · see citing works
Rheumatoid arthritis and salivary biomarkers of periodontal disease
Mirrielees, J., Crofford, L. J., Lin, Y., Kryscio, R. J., Dawson, D. R., Ebersole, J. L., & Miller, C. S. (2010) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01625.x · Cited by 131 · see citing works
Zhou, M., Rong, R., Munro, D. B., Zhu, C., Gao, X., Zhang, Q., & Dong, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061516 · Cited by 125 · see citing works
Demmer, R. T., Breskin, A., Rosenbaum, M. S., Zuk, A. M., LeDuc, C. A., Leibel, R. L., Paster, B. J., Desvarieux, M., Jacobs, D. R., & Papapanou, P. N. (2016) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12664 · Cited by 107 · see citing works
da Cruz, G. A., de Toledo, S., Sallum, E. A., Sallum, A. W., Ambrosano, G. M. B., Sardi, J. D. C. O., da Cruz, S. E. B., & Gonçalves, R. B. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.070503 · Cited by 98 · see citing works
Effect of Aging on Periodontal Inflammation, Microbial Colonization, and Disease Susceptibility
Wu, Y., Dong, G., Xiao, W., Xiao, E., Miao, F., Syverson, A. L., Missaghian, N., Vafa, R. P., Ortega, A., Rossa, C., et al. (2016) · Journal of Dental Research · doi:10.1177/0022034515625962 · Cited by 98 · see citing works
Self-citationQueiroz‐Junior, C. M., Madeira, M. F. M., Coelho, F. M., Costa, V. V., Bessoni, R. L. C., Sousa, L. F. D. C., Garlet, G. P., de Souza, D. D. G., Teixeira, M. M., & Silva, T. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101195 · Cited by 93 · see citing works
Self-citationAemaimanan, P., Amimanan, P., & Taweechaisupapong, S. (2013) · Anaerobe · doi:10.1016/j.anaerobe.2013.06.010 · Cited by 91 · see citing works
Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus
Jensen, J. L., Bergem, H. O., Gilboe, I.-M., et al. (1999) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1999.tb02047.x · Cited by 90 · see citing works
Ramamurthy, N. S., Greenwald, R. A., Celiker, M. Y., & Shi, E. (2005) · Journal of Periodontology · doi:10.1902/jop.2005.76.2.229 · Cited by 82 · see citing works
Inflammation is More Persistent in Type 1 Diabetic Mice
Graves, D. T., Naguib, G. H., Lu, H., Leone, C. W., Hsue, H., & Krall, E. A. (2005) · Journal of Dental Research · doi:10.1177/154405910508400406 · Cited by 81 · see citing works
Self-citationPeriodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy
Fabbri, C., Fuller, R., Bonfá, E., Guedes, L. K. N., D'Alleva, P. S. R., & Borba, E. F. (2014) · Clinical Rheumatology · doi:10.1007/s10067-013-2473-2 · Cited by 79 · see citing works
Rutter‐Locher, Z., Smith, T. O., Giles, I., & Sofat, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01295 · Cited by 78 · see citing works
Microbial Diversity and Interactions in Subgingival Biofilm Communities
Diaz, P. I. (2011) · Frontiers of oral physiology/Frontiers of oral biology · doi:10.1159/000329669 · Cited by 75 · see citing works
Gingival and periodontal health in systemic lupus erythematosus
Mutlu, S., Richards, A., Maddison, P. J., et al. (1993) · Community Dentistry And Oral Epidemiology · doi:10.1111/j.1600-0528.1993.tb00742.x · Cited by 61 · see citing works
Risk of Periodontitis in Systemic Lupus Erythematosus Is Associated with Fcγ Receptor Polymorphisms
Kobayashi, T., Ito, S., Yamamoto, K., et al. (2003) · Journal of Periodontology · doi:10.1902/jop.2003.74.3.378 · Cited by 57 · see citing works
Commentary: Periodontitis and Rheumatoid Arthritis: What Do We Know?
de Smit, M. J., Westra, J., Brouwer, E., Janssen, K. M. J., Vissink, A., & Winkelhoff, A. J. V. (2015) · Journal of Periodontology · doi:10.1902/jop.2015.150088 · Cited by 53 · see citing works
Marques, C. P. C., Victor, E. C., Franco, M. M., Fernandes, J. M. C., Maor, Y., de Andrade, M. S., Rodrigues, V. P., & Benatti, B. B. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.025 · Cited by 51 · see citing works
FOXO1 Deletion Reduces Dendritic Cell Function and Enhances Susceptibility to Periodontitis
Xiao, W., Dong, G., Pacios, S., Alnammary, M., Barger, L., Wang, Y., Wu, Y., & Graves, D. T. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.12.006 · Cited by 49 · see citing works
Self-citationCastrillón, C. A., Hincapié, J., Delgado, F. L. Y., Roldan, N., Moreno, S., Contreras, A., & Botero, J. E. (2013) · Journal of Investigative and Clinical Dentistry · doi:10.1111/jicd.12051 · Cited by 38 · see citing works
Association between Serum Antibodies to Oral Microorganisms and Hyperglycemia in Adults
Merchant, A. T., Shrestha, D., Chaisson, C., Choi, Y., Hazlett, L. J., & Zhang, J. (2014) · Journal of Dental Research · doi:10.1177/0022034514538451 · Cited by 35 · see citing works
Anbalagan, R., Srikanth, P., Mani, M., Barani, R., Seshadri, K., & Janarthanan, R. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.009 · Cited by 34 · see citing works
Šaferis, V. (2014) · Medical Science Monitor · doi:10.12659/msm.890879 · Cited by 31 · see citing works
Corrêa, J. D., Saraiva, A. M., Queiroz‐Junior, C. M., Madeira, M. F. M., Duarte, P. M., Teixeira, M. M., Souza, D. G., & Silva, T. A. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.03.006 · Cited by 30 · see citing works
Self-citationWang, H., Han, Q., Luo, Z., Xu, C.-X., Liu, J., Dan, H., Xu, Y., Zeng, X. Y., & Chen, Q. (2013) · Clinical Oral Investigations · doi:10.1007/s00784-013-1131-z · Cited by 29 · see citing works
Mendonça, S. M. S., Corrêa, J. D., de Souza, A. F., Travassos, D. V., Calderaro, D. C., Rocha, N. P., Vieira, É. L. M., Teixeira, A. L., Ferreira, G. A., & Silva, T. A. (2019) · PubMed · Cited by 26 · see citing works
Self-citationNAMPT Is an Essential Regulator of RA-Mediated Periodontal Inflammation
Kim, D., Lee, G., Huh, Y. H., Lee, S. Y., Park, K. H., Kim, S., Kim, J., Koh, J., & Ryu, J. (2017) · Journal of Dental Research · doi:10.1177/0022034517690389 · Cited by 25 · see citing works
Coelho, A. S. E. D. C., Paula, A. B., Mota, M., et al. (2018) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2017-0500 · Cited by 21 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Borgnakke WS, 2013, J Periodontol, 84
- Chapple ILC, 2013, J Periodontol, 40
- Kinane DF, 2017, Nat Rev Dis Prim, 3
- Mendonça SMS, 2018, Clin Exp Rheumatol [epub ahead of print 19 Jul 2018] in press
Cited by
Sorted by citations
Bioadhesion in the oral cavity and approaches for biofilm management by surface modifications
Sterzenbach, T., Helbig, R., Hannig, C., & Hannig, M. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-020-03646-1 · Cited by 212 · see citing works
Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection
Bao, L., Zhang, C., Dong, J., Zhao, L., Li, Y., & Sun, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01840 · Cited by 207 · see citing works
From nitrate to NO: potential effects of nitrate-reducing bacteria on systemic health and disease
Liu, H., Huang, Y., Huang, M., Wang, M., Ming, Y., Chen, W., Chen, Y., Tang, Z., & Jia, B. (2023) · European Journal of Medical Research · doi:10.1186/s40001-023-01413-y · Cited by 58 · see citing works
Dumitru, C. N., Dumitru, A. O., Popa, G. V., Marcu, T., Ursu, M., Nechita, A., & Matei, N. M. (2026) · Dentistry Journal · doi:10.3390/dj14050289 · Cited by 6 · see citing works
“Modifiable risk factors include smoking, poorly controlled diabetes mellitus, obesity, psychological stress, inadequate oral hygiene practices, and dietary factors [3,38,39].”
- Authors
- Graves, D. T., Corrêa, J. D., & Silva, T. A.
- Affiliations
- University of Pennsylvania (US)
- Universidade Federal de Minas Gerais (BR)
- Faculty of Dentistry, Federal University of Minas Gerais, Belo Horizonte, Brazil
- Corresponding author
- Graves, D.T.
- Venue
- Journal of Dental Research
- Publisher
- SAGE Publications
- Published
- 2018-10-25
- Volume
- 98
- Issue
- 2
- Pages
- 148-156
- ISSN
- 0022-0345 (ISSN-L)
- 1544-0591
- PMC
- PMC6761737
- OpenAlex
- W2898140240
- Semantic Scholar
- 58c4ce0841a04faa6c0870ccf298d83a37a7ccd3
- Cited by
- 423
- References
- 72
- Citations by year
- 2026: 56 · 2025: 71 · 2024: 59 · 2023: 61 · 2022: 56 · 2021: 68 · 2020: 36 · 2019: 14
- FWCI
- 33.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Dental Research (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NIH (R01 DE017732)
- Topics
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › General Dentistry › Dental Research and COVID-19
- Keywords
- oral microbiota, periodontitis, systemic disease, diabetes mellitus, rheumatoid arthritis, systemic lupus erythematosus, oral dysbiosis, IL-17, periodontal inflammation, Capnocytophaga, Porphyromonas, Pseudomonas, Prevotella, Selenomonas, Leptotrichia, osteoclastogenesis, periodontal bone loss, leukocyte adhesion deficiency
- MeSH terms
- Animals, Bacteria, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Mouth, Periodontitis, Periodontium, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review